tiprankstipranks
Trending News
More News >
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market
Advertisement

Halozyme (HALO) Technical Analysis

Compare
1,092 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
2Neutral
11Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Halozyme Therapeutics’s (HALO) Moving Averages Convergence Divergence (MACD) indicator is -1.90, suggesting Halozyme Therapeutics is a Buy.
Halozyme Therapeutics’s (HALO) 20-Day exponential moving average is 70.45, while Halozyme Therapeutics’s (HALO) share price is $64.1, making it a Sell.
Halozyme Therapeutics’s (HALO) 50-Day exponential moving average is 69.49, while Halozyme Therapeutics’s (HALO) share price is $64.1, making it a Sell.

Halozyme (HALO) Pivot Points

Oct 11, 2025, 03:52 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
62.90
63.54
64.33
64.97
65.76
66.40
67.19
Fibonacci
63.54
64.09
64.43
64.97
65.52
65.86
66.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (HALO) Moving Averages

Oct 11, 2025, 03:52 PM
Period
Simple
Exponential
MA5
65.48Sell
65.91Sell
MA10
68.96Sell
68.19Sell
MA20
72.57Sell
70.45Sell
MA50
70.80Sell
69.49Sell
MA100
62.99Buy
65.82Sell
MA200
60.47Buy
61.65Buy
Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 68.19, while Halozyme Therapeutics’s (HALO) share price is $64.1, making it a Sell.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 65.82, while Halozyme Therapeutics’s (HALO) share price is $64.1, making it a Sell.
Halozyme Therapeutics’s (HALO) stock price is $64.1 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 70.80, creating a Sell signal.
Halozyme Therapeutics’s (HALO) stock price is $64.1 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 62.99, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $64.1 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 60.47, creating a Buy signal.

Halozyme (HALO) Technical Indicators

Oct 11, 2025, 03:52 PM
Name
Value
Implied Action
RSI (14)
25.68
Buy
STOCH (9,6)
5.04
Buy
STOCHRSI (14)
3.98
Buy
MACD (12,26)
-1.90
Buy
ADX (14)
37.94
Neutral
Williams %R
-97.96
Buy
CCI (14)
-141.04
Buy
ATR (14)
2.14
-
Ultimate Oscillator
32.60
Neutral
ROC
-18.11
Sell
Halozyme Therapeutics’s (HALO) Relative Strength Index (RSI) is 25.68, creating a Buy signal.
Halozyme Therapeutics’s (HALO) Trend Strength Indicator (ADX) is 37.94, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Commodity Channel Index (CCI) is -141.04, creating a Buy signal.
Halozyme Therapeutics’s (HALO) Price Rate of Change (ROC) is -18.11, creating a Sell signal.

FAQ

Is HALO a Buy, Hold, or Sell?
Based on HALO’s technical indicators, HALO is a Hold.
    What is HALO’s RSI (14)?
    HALO’s RSI (14) is 25.68, which suggests HALO is a Buy.
      What is HALO’s MACD?
      HALO’s MACD is -1.90, which suggests HALO is a Buy.
        What is HALO’s 5-day moving average?
        HALO’s 5-day moving average is 65.48, which suggests HALO is a Sell.
          What is HALO’s 20-day moving average?
          HALO 20-day moving average is 72.57, which suggests HALO is a Sell.
            What is HALO’s 50-day moving average?
            HALO’s 50-day moving average is 70.80, which suggests HALO is a Sell.
              What is HALO’s 200-day moving average?
              HALO’s 200-day moving average is 60.47, which suggests HALO is a Buy.
                What is HALO’s Williams % R (14)?
                HALO’s Williams % R (14) is -97.96, which suggests HALO is a Buy.
                  What is HALO’s CCI (14)?
                  HALO’s CCI (14) is -141.04, which suggests HALO is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis